Fc-interferon-beta fusion proteins

Details for Australian Patent Application No. 2005256519 (hide)

Owner Merck Patent GmbH

Inventors Baker, Matthew Paul; Gillies, Stephen D.; Lo, Kin-Ming; Watkins, Nigel John

Agent Davies Collison Cave

Pub. Number AU-B-2005256519

PCT Pub. Number WO2006/000448

Priority 60/583,389 28.06.04 US

Filing date 28 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 13 October 2011

International Classifications

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/565 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/22 (2006.01) Mutation or genetic engineering

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/000448 Priority application(s): WO2006/000448

13 September 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Lo, King-Ming to Lo, Kin-Ming

13 October 2011 Application Accepted

  Published as AU-B-2005256519

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005256523-Order management system

2005256514-Gas-insulated medium-voltage switchgear